Claims for Patent: 10,398,681
✉ Email this page to a colleague
Summary for Patent: 10,398,681
| Title: | Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions |
| Abstract: | Disclosed herein are compounds and compositions thereof which find use in increasing stability of proteins particularly proteins that tend to misfold and form aggregates. Also provided herein are methods for using these compounds and compositions for increasing stability of proteins and thereby decreasing aggregate formation by these proteins. Also disclosed herein are heterobifunctional compounds that include a TTR binding compound connected to a targeting moiety via a linker, for use in disrupting PPIs of a target protein. |
| Inventor(s): | Isabella A. Graef, Mamoun M. Alhamadsheh |
| Assignee: | Leland Stanford Junior University |
| Application Number: | US15/883,750 |
Details for Patent 10,398,681
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Zenpep, Llc | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | August 27, 2009 | ⤷ Get Started Free | 2038-01-30 |
| Zenpep, Llc | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | June 15, 2011 | ⤷ Get Started Free | 2038-01-30 |
| Zenpep, Llc | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | July 13, 2011 | ⤷ Get Started Free | 2038-01-30 |
| Zenpep, Llc | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | March 25, 2014 | ⤷ Get Started Free | 2038-01-30 |
| Zenpep, Llc | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | October 27, 2023 | ⤷ Get Started Free | 2038-01-30 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,398,681
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2014100227 | ⤷ Get Started Free |
| United States of America | 9913826 | ⤷ Get Started Free |
| United States of America | 9642838 | ⤷ Get Started Free |
| United States of America | 9169214 | ⤷ Get Started Free |
| United States of America | 2025186399 | ⤷ Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
